Hims & Hers Health (HIMS) said Wednesday it has acquired at-home lab testing provider Sigmund, or Trybe Labs, to allow the company to offer at-home blood testing.
Financial terms were not disclosed.
The company said it funded the purchase with cash on hand and expects to introduce at-home testing over the next year.
Shares of Hims & Hers were up more than 4% in early trading Wednesday.
Price: 60.95, Change: +2.45, Percent Change: +4.19
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。